AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2011
Nov 4, 2011
29875_dirs_2011-11-04_aa2f74c1-fa9b-4b23-9f15-4df2e3826f2e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2011-11-02
Reporting Person: BANKS EDWIN M (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-11-02 | Share Credits | $0 | A | 2725.7478 | Acquired | Common Stock (2725.7478) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 23187 | Direct |
| Common Stock | 1000 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $9.17 | 2013-02-25 | Common Stock (46849) | 46849 | Direct |
| Stock Option | $13.41 | 2014-01-02 | Common Stock (46856) | 46856 | Direct |
| Stock Option | $20.23 | 2015-03-01 | Common Stock (33739) | 33739 | Direct |
| Stock Option | $27.12 | 2016-03-01 | Common Stock (33726) | 33726 | Direct |
Footnotes
F1: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan.
F2: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election.
F3: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Declaration of Voting Results & Voting Rights Announcements
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3